BabyCathy2014-07-24 08:31
$PUMA BIOTECHNOLOGY INC(PBYI)$ 浙江医药(600216.SH)与美国AMBRX公司合作研发并商业化许可产品--аHer2-ADC产品。该产品是用于乳腺癌适应症的单克隆抗体药物偶联物候选药物,属于国际上近几年癌症治疗领域创新开发的技术和药物。查看全文
小马要过河2014-07-24 04:55
$PUMA BIOTECHNOLOGY INC(PBYI)$ 看了一下关于新药的报道以及13年癌症报告,截取了一些关键点。怕翻译不准确,直接复制了:patients receiving neratinib showed a whopping 33% increase in disease-free survival, or DFS, compared to placebo. The company plans on filing for regulatory app...查看全文
$Puma Biotechnology(PBYI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-24-022063 Size: 5 KB 网页链接
$Puma Biotechnology(PBYI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-24-022067 Size: 5 KB 网页链接
$Puma Biotechnology(PBYI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-24-022065 Size: 5 KB 网页链接
$Puma Biotechnology(PBYI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-24-022061 Size: 5 KB 网页链接
$Puma Biotechnology(PBYI)$ 144 Report of proposed sale of securities Accession Number: 0001610717-24-000386 Act: 33 Size: 4 KB 网页链接
$Puma Biotechnology(PBYI)$ 144 Report of proposed sale of securities Accession Number: 0001610717-24-000388 Act: 33 Size: 4 KB 网页链接
$Puma Biotechnology(PBYI)$ 144 Report of proposed sale of securities Accession Number: 0001610717-24-000387 Act: 33 Size: 4 KB 网页链接
$Puma Biotechnology(PBYI)$ 144 Report of proposed sale of securities Accession Number: 0001610717-24-000385 Act: 33 Size: 5 KB 网页链接
$Puma Biotechnology(PBYI)$ 8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0001437749-24-021086 Act: 34 Size: 207 KB 网页链接
$Puma Biotechnology(PBYI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-24-021024 Size: 6 KB 网页链接